Dalbagni G - Search Results

1

Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.

Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner BH. Pettus JA, et al. Among authors: dalbagni g. Eur Urol. 2008 Feb;53(2):370-5. doi: 10.1016/j.eururo.2007.07.031. Epub 2007 Jul 26. Eur Urol. 2008. PMID: 17689003

2

Cell surface differentiation antigens of normal urothelium and bladder tumors.

Dalbagni G, Reuter VE, Sheinfeld J, Fradet Y, Fair WR, Cordon-Cardo C. Dalbagni G, et al. Semin Surg Oncol. 1992 Sep-Oct;8(5):293-9. doi: 10.1002/ssu.2980080508. Semin Surg Oncol. 1992. PMID: 1462100 Review.

3

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.

Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE. Cordon-Cardo C, et al. Among authors: dalbagni g. J Natl Cancer Inst. 1992 Aug 19;84(16):1251-6. doi: 10.1093/jnci/84.16.1251. J Natl Cancer Inst. 1992. PMID: 1640484

4

Experience with potency preservation during radical prostatectomy. Significance of learning curve.

Surya BV, Provet J, Dalbagni G, Johanson KE, Brown J. Surya BV, et al. Among authors: dalbagni g. Urology. 1988 Dec;32(6):498-501. doi: 10.1016/s0090-4295(98)90028-0. Urology. 1988. PMID: 3201656

5

Deletion of the p16 and p15 genes in human bladder tumors.

Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D, Cordon-Cardo C. Orlow I, et al. Among authors: dalbagni g. J Natl Cancer Inst. 1995 Oct 18;87(20):1524-9. doi: 10.1093/jnci/87.20.1524. J Natl Cancer Inst. 1995. PMID: 7563186

6

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE. Sarkis AS, et al. Among authors: dalbagni g. J Natl Cancer Inst. 1993 Jan 6;85(1):53-9. doi: 10.1093/jnci/85.1.53. J Natl Cancer Inst. 1993. PMID: 7677935

7

Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.

Dalbagni G, Cordon-Cardo C, Reuter V, Fair WR. Dalbagni G, et al. Surg Oncol Clin N Am. 1995 Apr;4(2):231-40. Surg Oncol Clin N Am. 1995. PMID: 7796283 Review.

8

Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.

Dalbagni G, Presti JC Jr, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. Dalbagni G, et al. Diagn Mol Pathol. 1993 Mar;2(1):4-13. Diagn Mol Pathol. 1993. PMID: 7904525

9

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns.

Cordon-Cardo C, Dalbagni G, Saez GT, Oliva MR, Zhang ZF, Rosai J, Reuter VE, Pellicer A. Cordon-Cardo C, et al. Among authors: dalbagni g. Int J Cancer. 1994 Feb 1;56(3):347-53. doi: 10.1002/ijc.2910560309. Int J Cancer. 1994. PMID: 7906253

10

Genetic alterations associated with bladder cancer.

Cordon-Cardo C, Dalbagni G, Sarkis AS, Reuter VE. Cordon-Cardo C, et al. Among authors: dalbagni g. Important Adv Oncol. 1994:71-83. Important Adv Oncol. 1994. PMID: 7911446 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters